Spin-outs on the rise as companies try to win out in desolate M&A market
Swiss drug giant Novartis AG (ADR) (NYSE:NVS) has just completed the spin-off of Sandoz, its generics and biosimilars business. Kelloggs has done the same,...
Source: proactiveinvestors.com